FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085532 [Registered on: 24/04/2025] Trial Registered Prospectively
Last Modified On: 23/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparing the effect of Daruharidra and Amalaki beej in Shwetapradara (abnormal vaginal discharge) 
Scientific Title of Study   Randomised comparitive clinical study to evaluate the efficacy of Daruharidra and Amalaki Beej in Shwetapradara w.s.r to abnormal vaginal discharge  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Karishma Bhadra 
Designation  PG Scholar Of Dravya Guna Vigyan Vibhag 
Affiliation  Madan Mohan Malviya Government Ayurved College 
Address  Department of Dravyaguna Vigyan, Madan Mohan Malviya Government Ayurved College Ambamata Scheme Radaji Circle Udaipur Rajasthan 313001

Udaipur
RAJASTHAN
313001
India 
Phone  8286717784  
Fax    
Email  karishbhadra2209@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ashwini Kumar Sharma 
Designation  Professor and Head Of Department Of Dravya Guna Vigyan Vibhag 
Affiliation  Madan Mohan Malviya Government Ayurved College 
Address  Department of Dravyaguna Vigyan, Madan Mohan Malviya Government Ayurved College Ambamata Scheme Radaji Circle Udaipur Rajasthan 313001

Udaipur
RAJASTHAN
313001
India 
Phone  9929093470  
Fax    
Email  drashwinisharma1972@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Karishma Bhadra 
Designation  PG Scholar Of Dravya Guna Vigyan Vibhag 
Affiliation  Madan Mohan Malviya Government Ayurved College 
Address  Department of Dravyaguna Vigyan, Madan Mohan Malviya Government Ayurved College Ambamata Scheme Radaji Circle Udaipur Rajasthan 313001

Udaipur
RAJASTHAN
313001
India 
Phone  8286717784  
Fax    
Email  karishbhadra2209@gmail.com  
 
Source of Monetary or Material Support  
From Madan Mohan Malviya Government College Pharmacy,udaipur 313001. If not available from Madan Mohan Malviya Government College Pharmacy then from market 
 
Primary Sponsor  
Name  Madan Mohan Malviya Government Ayurved College 
Address  Madan Mohan Malviya Government Ayurved College Ambamata Scheme Radaji Circle Udaipur Rajasthan 313001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Karishma Bhadra  Government Ayurved Hospital Motichohattah   OPD Room No 6, Govt Ayurved Hospital(Attached hospital to Madan Mohan Malviya Govt Ayurved College) Motichohattah Udaipur Rajasthan India 313001
Udaipur
RAJASTHAN 
8286717784

karishbhadra2209@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Madan Mohan Malviya Government Ayurved College Udaipur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N768||Other specified inflammation of vagina and vulva. Ayurveda Condition: SOMAROGAH/SVETAPRADARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Daruharidra, Reference: Gadanigraha, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: water), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Amalaki Beej, Reference: Charak Samhita, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: water), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Female 
Details  Female patients with signs and symptoms of shwetapradara (abnormal vaginal discharge)
Age between 18 to 50 female patient
Female who are willing to participate 
 
ExclusionCriteria 
Details  Pregnant and lactating women
Patients with known history of STD
Abnormal uterine bleeding
vaginal discharge occurring due to intrauterine contraceptive device
Patients with Oral Contraceptive PillS
Patients with ca cervix and other gynacological problems like ovarian cyst, uterine prolapse, uterine fibromyoma etc

5)Patients with Oral Contraceptive PillS

6) Patients with ca cervix and other gynacological problems like ovarian cyst, uterine prolapse, uterine fibromyoma, etc 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Changes in the signs and symptoms of sveta pradara (Abnormal vaginal discharge) - Yonigata sravah, varna, vedana, kandu, katishula, dourbalya, mutradaha, consistency of vaginal discharge, yoni dourgandhya, vaginal ph  60 days 
 
Secondary Outcome  
Outcome  TimePoints 
identification & authentication of drugs  15 days, 30days, 45days,60 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   02/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This Study is about  Pharmacognostical and Clinical study of Daruharidra and Amlaki beej in Shwetpradara W.S.R to Abnormal vaginal discharge.There will
be 2 Groups for the study,

In Group A - Druharidra choorna 3mg ( one time ) = BD = 6 gm/day will be
given.
In Group B - Amlaki beej choorna 3mg ( one time ) = BD = 6 gm/day will be
given.

Trial will be conduct for a period of 2 months (60 days ) Follow up of the case will be after every 15
days that is 4 times ( At 15 days ,At 30 days ,At 45 days, At 60 days) during treatment. Final assessment will be
done after completion of 2 months of treatment course on the basis of subjective, objective
assessment and laboratory investigation.
The data will be analyzed scientifically and statistically
 
Close